HCA Healthcare, Inc. $HCA Shares Purchased by Inscription Capital LLC

Inscription Capital LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 46.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,839 shares of the company’s stock after purchasing an additional 1,845 shares during the quarter. Inscription Capital LLC’s holdings in HCA Healthcare were worth $2,489,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Root Financial Partners LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth about $178,000. Vista Investment Partners II LLC boosted its position in HCA Healthcare by 1.6% during the third quarter. Vista Investment Partners II LLC now owns 5,583 shares of the company’s stock worth $2,379,000 after purchasing an additional 88 shares in the last quarter. William B. Walkup & Associates Inc. acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $59,000. Fisher Funds Management LTD grew its stake in HCA Healthcare by 48.3% in the 3rd quarter. Fisher Funds Management LTD now owns 119,412 shares of the company’s stock valued at $50,893,000 after acquiring an additional 38,876 shares during the period. Finally, Arkadios Wealth Advisors lifted its holdings in HCA Healthcare by 28.3% during the third quarter. Arkadios Wealth Advisors now owns 4,492 shares of the company’s stock valued at $1,915,000 after purchasing an additional 991 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 3.0%

HCA opened at $469.08 on Tuesday. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $520.00. The stock’s 50-day moving average price is $480.68 and its 200 day moving average price is $431.78. The firm has a market cap of $107.04 billion, a price-to-earnings ratio of 18.13, a PEG ratio of 1.29 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter last year, the company posted $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research note on Monday, December 15th. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research note on Monday, October 27th. Stephens boosted their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Finally, Leerink Partners lifted their target price on shares of HCA Healthcare from $470.00 to $507.00 and gave the stock an “outperform” rating in a research note on Thursday, January 15th. Fifteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $487.00.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.